Sensei Biotherapeutics Inc

NASDAQ:SNSE   3:59:53 PM EDT
1.71
+0.08 (+4.91%)
Earnings Announcements

Sensei Biotherapeutics Reports First Quarter 2022 Financial Results And Recent Business Highlights

Published: 05/10/2022 11:37 GMT
Sensei Biotherapeutics Inc (SNSE) - Sensei Biotherapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights.
Sensei Biotherapeutics Inc - Expects Current Cash Balance to Fund Operations Into Q1 of 2025.
Sensei Biotherapeutics Inc - Qtrly Net Loss per Share $0.40.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.40

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.42

More details on our Analysts Page.